Local treatment for prostate cancer that has spread to a few spots
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
The trial looks at how well local treatment (surgery or radiation) works for prostate cancer that has spread to only a few places, as found on a PSMA PET scan. It aims to see if treating the prostate and its local spread can help people live longer or better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer has spread to only a few spots (5 or fewer) outside the prostate, like bones or lymph nodes, as seen on a special PSMA PET scan.
- You have already had, or are planning to have, local treatment to the prostate itself (surgery or radiation).
- Any Gleason score (cancer grade), any tumor stage, and any PSA level are allowed.
- You do not have cancer spread to organs like the liver or brain (lung spots are okay).
- You have not received chemotherapy or other systemic treatment before the first PSMA PET scan.
- You had the PSMA PET scan before starting local treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether treating only a small number of prostate cancer metastases can help people with “oligorecurrent” (limited repeat) prostate cancer. It may reduce cancer activity while avoiding broader whole-body treatment for some patients.
This trial tests a combination of two treatments for men with prostate cancer that has spread to a small number of sites: a radioactive injection (177Lu-PSMA-617) that targets cancer cells, plus hormone-blocking medication. The goal is to control the cancer and delay progression.
This trial is testing whether giving radiation to all spots of cancer that show up on a PSMA PET scan works better than giving radiation only to the main tumor in the prostate. It is for men whose prostate cancer has spread to a few other places (up to 10 spots).
This study tests whether adding a type of high-precision radiation (MDRT) to standard hormone therapy works better for men with prostate cancer that has spread to just a few places. It is for patients who are newly diagnosed and on long-term hormone therapy.
This trial looks at whether a precise form of radiation (stereotactic body radiotherapy) can control a small number of prostate cancer spots seen on a special scan (PSMA PET/CT). It may help by treating limited metastases while avoiding unnecessary treatment elsewhere.
This trial studies whether operating on a small, one-sided (unilateral) area of prostate cancer spread in the pelvic lymph nodes—found on a PSMA PET scan—can help control recurrence. It’s meant for people whose PSA is still low and whose spread appears limited on the scan.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.